Lido Advisors LLC Grows Stock Position in Integer Holdings Co. (NYSE:ITGR)

Lido Advisors LLC boosted its position in Integer Holdings Co. (NYSE:ITGR) by 31.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,742 shares of the medical equipment provider’s stock after purchasing an additional 655 shares during the quarter. Lido Advisors LLC’s holdings in Integer were worth $363,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mather Group LLC. grew its position in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 143 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in Integer in the 4th quarter valued at $27,000. R Squared Ltd acquired a new stake in shares of Integer in the 4th quarter worth $44,000. Sterling Capital Management LLC raised its holdings in shares of Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock worth $45,000 after acquiring an additional 279 shares during the period. Finally, Versant Capital Management Inc boosted its position in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 183 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Insider Activity

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.16% of the company’s stock.

Integer Stock Performance

Shares of Integer stock opened at $116.45 on Tuesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $4.06 billion, a price-to-earnings ratio of 34.66, a price-to-earnings-growth ratio of 1.72 and a beta of 1.03. The business has a 50-day moving average of $118.64 and a 200 day moving average of $129.99. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same quarter in the previous year, the business posted $1.14 earnings per share. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ITGR shares. Benchmark decreased their target price on shares of Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a report on Friday, April 25th. KeyCorp decreased their price objective on Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Truist Financial set a $150.00 target price on Integer and gave the stock a “buy” rating in a research note on Friday, April 25th. StockNews.com lowered Integer from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Finally, Raymond James raised their price objective on Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, April 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.